Skip to main content
Victor Perez, MD, Ophthalmology, Durham, NC

VictorLPerezMD

Ophthalmology Durham, NC

Cataract Related, Cornea & External Disease, Uveitis

Professor of Opthalmology Microbiology & Immunology Walter G. Ross Chair in Ophthalmic Research Director Ocular Surface Center

Dr. Perez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Perez's full profile

Already have an account?

  • Office

    Duke Eye Center Dumc3802 2351 Erwin Road
    Durham, NC 27710
    Phone+1 919-684-5769
    Fax+1 919-681-7661

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1997 - 2000
  • Boston University Medical Center
    Boston University Medical CenterResidency, Surgery, 1991 - 1995
  • University of Puerto Rico School of Medicine
    University of Puerto Rico School of MedicineClass of 1991

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2006 - 2025
  • NC State Medical License
    NC State Medical License 2017 - 2025
  • OH State Medical License
    OH State Medical License 2002 - 2008
  • American Board of Ophthalmology Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Bascom Palmer Receives Multimillion Dollar Award to Support Functional Whole-Eye Transplant
    Bascom Palmer Receives Multimillion Dollar Award to Support Functional Whole-Eye TransplantDecember 2nd, 2024
  • PRGF Eye Drops Appear Safe, Effective in Dry Eyes
    PRGF Eye Drops Appear Safe, Effective in Dry EyesNovember 9th, 2022
  • Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-in Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease
    Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-in Cohort of Phase 3 TRANQUILITY Trial in Dry Eye DiseaseJanuary 7th, 2021

Professional Memberships